OVERVIEW: Neuroendocrine Tumor Imaging
Users of this tutorial will learn how to name the three radiopharmaceuticals suitable for use in detection of neuroendocrine tumors and their required storage conditions, the most common indications for ordering this test, the prescribed injected dose for each, patient preparation and thyroid blockage (as required) for each of these drugs, the time and imaging parameters for planar and SPECT imaging, understand the sites of localization of each drug in a normal patient and be able to identify neuroendocrine tumors on scans typical of the disease.
● Radiopharmaceuticals Utilized in Neuroendocrine Tumor Imaging
- 123I mIBG and 131 I mIBG
- 111In-Octreoscan (111In-Pentetreotide)
|